Pegah Varamini

About Dr. Pegah Varamini

Dr. Pegah Varamini is a Senior Lecturer in Pharmacy and Pharmacology at the Sydney Pharmacy School, University of Sydney, and a Casual Lecturer in Music Education at the Sydney Conservatorium of Music. She leads the Breast Cancer Targeting & Drug Delivery (BCTDD) Group, focusing on innovative drug delivery systems for Triple Negative Breast Cancer (TNBC). Her research integrates nanotechnology, targeted therapy, and translational medicine, supported by prestigious grants including the NBCF Fellowship (2016).

Research & Education

• PharmD (Shiraz University of Medical Sciences)
• PhD in Pharmaceutical Sciences (University of Queensland)
• Second PhD in Music Education (University of Sydney Conservatorium of Music)

Key Research Interests

Her work centers on:

• Peptide-based targeting strategies using 'Trojan Horse' approaches for TNBC
• Development of nanomedicine for bone metastasis prevention
• Clinically relevant preclinical models for personalized breast cancer treatment
• Collaborations with international institutions (e.g., Harvard Medical School, University of Nantes)

Teaching & Supervision

Dr. Varamini coordinates Drug Design and Development (PCOL3012/3912) and supervises a multidisciplinary team of HDR students and postdoctoral researchers. Notable current students include PhD candidate Hany Ghaly and MPhil candidates Huimin Shao and Farhana Mollah.

Awards & Recognition

• 2021 Equity Prize
• 2016 Top 25 Young Researchers of Australia and New Zealand
• 2018 Fresh Scientist of the Year
• Recipient of multiple grants totaling over AUD 2M

Leadership & Outreach

She co-chairs the Nanopharma cluster at Sydney Nano Institute and advises the WHO Global Breast Cancer Initiative. Her work has been featured in media outlets such as SBS Farsi News and NBCF publications.